.jpg "Timothy R. Donahue, MD photo")
Professor and Chief
David Geffen School of Medicine at UCLA
Los Angeles, CA, United States
Timothy R. Donahue, MD is a Professor of Surgery at the David Geffen School of Medicine at UCLA. He has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Chief of the Division of Surgical Oncology and Vice Chair for Cancer Care in the Department of Surgery. In addition, Dr. Donahue is also the Program Director of the General Surgery Residency Program at UCLA. He is committed to training the next generation of surgeon-scientists, a career path he strongly believes is still viable. Dr. Donahue is a very busy GI oncologic surgeon, focusing on gastric and pancreatic surgery. His clinical research is focused on improving treatment approaches for patients with gastric and pancreatic cancer. Dr. Donahue is a strong advocate of prolonged preoperative chemo or radiation therapy to optimally select for those who will benefit from a surgical resection. In addition to his clinical work, Dr. Donahue is the Principal Investigator of a National Institutes of Health funded research laboratory. His scientific research focuses on developing improved treatment strategies and earlier diagnostic markers for patients with pancreatic cancer. He is optimistic that therapy for pancreatic and gastric cancer will markedly improve during his career.
Interscope (Individual(s) Involved: Self): Consultant; PrecisCa (Individual(s) Involved: Self): Speaker/Honoraria; Trethera Corporation (Individual(s) Involved: Self): stock options
Friday, March 11, 2022
2:30 PM – 3:00 PM CST